Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2. | Int J Mol Sci | 2022 | 35408790 | PubTator, text mining | PubMed |
| Construction of disease-specific cytokine profiles by associating disease genes with immune responses. | PLoS Comput Biol | 2022 | 35404985 | PubTator, text mining | PubMed |
| Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics. | Theranostics | 2022 | 35401838 | PubTator, text mining | PubMed |
| Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals. | Front Immunol | 2022 | 35401538 | PubTator, text mining | PubMed |
| A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis. | Acta Neuropathol Commun | 2022 | 35395831 | PubTator, text mining | PubMed |
| Blockade of the CXCR3/CXCL10 axis ameliorates inflammation caused by immunoproteasome dysfunction. | JCI Insight | 2022 | 35393946 | PubTator, text mining | PubMed |
| Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. | J Immunother Cancer | 2022 | 35383115 | PubTator, text mining | PubMed |
| Multifunctional role of exosomes in viral diseases: From transmission to diagnosis and therapy. | Cell Signal | 2022 | 35367363 | PubTator, text mining | PubMed |
| Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness. | Nat Commun | 2022 | 35365638 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion. | Cancer Res | 2022 | 35363853 | PubTator, text mining | PubMed |
| Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry. | RSC Chem Biol | 2022 | 35360884 | PubTator, text mining | PubMed |
| Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm. | Front Immunol | 2022 | 35359938 | PubTator, text mining | PubMed |
| PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade. | Cell Rep | 2022 | 35354055 | PubTator, text mining | PubMed |
| Integrative Analysis of Gene Expression and DNA Methylation Depicting the Impact of Obesity on Breast Cancer. | Front Cell Dev Biol | 2022 | 35350384 | PubTator, text mining | PubMed |
| Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection. | Ann Transplant | 2022 | 35347104 | PubTator, text mining | PubMed |
| Long-term outcomes of refractory esophageal strictures after endoscopic submucosal dissection of superficial esophageal neoplasms. | BMC Gastroenterol | 2022 | 35346083 | PubTator, text mining | PubMed |
| Development of Peptide-Based Vaccines for Cancer. | J Oncol | 2022 | 35342400 | PubTator, text mining | PubMed |
| Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes. | BMC Med | 2022 | 35341481 | PubTator, text mining | PubMed |
| Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation. | Biomolecules | 2022 | 35327634 | PubTator, text mining | PubMed |
| The Proteome of Antibody-Mediated Rejection: From Glomerulitis to Transplant Glomerulopathy. | Biomedicines | 2022 | 35327371 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=41